(Q40651230)

22 September 2017

Ceftazidime and ciprofloxacin as empiric therapy in febrile neutropenic patients undergoing hematopoietic stem cell transplantation (English)

1 reference

22 September 2017

1 reference

Ghazal HH

1

1 reference

PubMed ID

9220216

22 September 2017

Ghazal CD

series ordinal

2

1 reference

PubMed ID

9220216

22 September 2017

Tabbara IA

series ordinal

3

1 reference

22 September 2017

1 May 1997

1 reference

22 September 2017

Clinical Therapeutics

1 reference

22 September 2017

19

1 reference

22 September 2017

3

1 reference

22 September 2017

520-526

1 reference

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

Empiric treatment of infections in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

A Comparison of Imipenem to Ceftazidime With or Without Amikacin as Empiric Therapy in Febrile Neutropenic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

Ceftazidime Monotherapy for Empiric Treatment of Febrile Neutropenic Patients: A Metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

Self-administered antibiotic therapy for chemotherapy-induced, low-risk febrile neutropenia in patients with nonhematologic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980136-1

7 January 2021

10.1016/S0149-2918(97)80136-1

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

9220216